NCT05187221

Brief Summary

CVS-F4 questionnaire will be used as an instrument to survey CVS prevalence and severity among medical students

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8,085

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2021

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 23, 2021

Completed
7 days until next milestone

Study Start

First participant enrolled

December 30, 2021

Completed
12 days until next milestone

First Posted

Study publicly available on registry

January 11, 2022

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 20, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2022

Completed
Last Updated

May 29, 2024

Status Verified

May 1, 2024

Enrollment Period

5 months

First QC Date

December 23, 2021

Last Update Submit

May 26, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Number of participants suffering from CVS

    will be reported in form of percentage (%) of students with CVS

    3 months

  • Rate of CVS symptoms-attacks

    The results will be presented as annual percentage

    3 months

Study Arms (1)

Control Group

The participants will respond to CVS-F4 questionnaire online via SurveyMonkey to report their potential CVS complains and associated screen factors as screen-time, screen-size, screen-resolution and other factors. This group will contains participants with no CVS complains.

Behavioral: CVS Group

Interventions

CVS GroupBEHAVIORAL

CVS-F4 will be an online survey via the SurveyMonkey Company. The participants will report their potential CVS complains and associated screen factors as screen-time, screen-size, screen-resolution and other factors. We will collect the responses and analyse the results. Informed consent will be obtained from the participants as an item within the survey itself that he/she agrees to use his/her data in this research work. This group will contain participants with CVS complains.

Control Group

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

medical students or staff who are using screens in their medical studies or personal lives and how these screens affect their medical studies and the effect of mandated medical computer use if present on their screen-behaviour and associated risk factor

You may qualify if:

  • university students
  • university staff members

You may not qualify if:

  • ocular surgery
  • amblyopia
  • anisometropia
  • strabismus
  • systemic disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Faculty of medicine

Sohag, Sohag Governorate, 82425, Egypt

Location

Faculty of medicine

Sohag, 82425, Egypt

Location

Study Officials

  • Mohammed Iqbal, MD, PhD

    Professor of Ophthalmology

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Ophthalmology

Study Record Dates

First Submitted

December 23, 2021

First Posted

January 11, 2022

Study Start

December 30, 2021

Primary Completion

May 20, 2022

Study Completion

September 1, 2022

Last Updated

May 29, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will share

Locations